Novo Nordisk A/S (NOVO-B.CO)
270.15 DKK -0.02%
Novo Nordisk A/S fell 0.02% in the latest session, at 270.15 DKK. By market cap it is number 1 of the 9 health care stocks on the C25 heatmap. Its trailing P/E of 10.3 is below the median of those peers (36.3). The price is 34.1% below its 52-week high.
Key numbers
- Price
- 270.15 DKK
- Day change
- -0.02% (-0.05)
- Market cap
- 1.19T DKK
- P/E (trailing)
- 10.3
- P/E (forward)
- 12.2
- Dividend yield
- 4.33%
- 50-day average
- 269.53
- 200-day average
- 284.35
- 52-week range
- 224.25 – 409.95
- Next earnings
- 4 Nov 2026
- Dividend per share (annual)
- 11.70 DKK
Data as of 3 Nov 2026, 16:59 CET. Market data may be delayed.
Novo Nordisk A/S over the past year
From daily closing prices. The highest close in the period was 401.35 DKK on 23 Jan 2026, the lowest 228.50 DKK on 27 Mar 2026.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +8.60% | -12.17% | -5.51% | -16.94% | -14.29% |
| Month | Close (DKK) | Change |
|---|---|---|
| November 2026 | 270.15 | +1.52% |
| October 2026 | 266.10 | +5.09% |
| September 2026 | 253.20 | -13.41% |
| August 2026 | 292.40 | -4.60% |
| July 2026 | 306.50 | -2.57% |
| June 2026 | 314.60 | +7.39% |
| May 2026 | 292.95 | +7.60% |
| April 2026 | 272.25 | +17.91% |
| March 2026 | 230.90 | -2.94% |
| February 2026 | 237.90 | -35.62% |
| January 2026 | 369.55 | +13.62% |
| December 2025 | 325.25 | +2.60% |
Health care peers
Novo Nordisk A/S is on the C25 heatmap (Health care). How it compares with the other health care stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Novo Nordisk A/S NOVO-B.CO | -0.02% | 1.19T DKK | 10.3 |
| Genmab A/S GMAB.CO | +0.57% | 229B DKK | 45.9 |
| Coloplast A/S COLO-B.CO | +2.97% | 112B DKK | 36.3 |
| Demant A/S DEMANT.CO | -0.97% | 77.1B DKK | 31.9 |
| ALK-Abelló A/S ALK-B.CO | +0.65% | 54.7B DKK | 40.5 |
| Ambu A/S AMBU-B.CO | +0.86% | 21.5B DKK | 42.9 |
| Bavarian Nordic A/S BAVA.CO | -2.71% | 18.2B DKK | 12.5 |
| GN Store Nord A/S GN.CO | +0.71% | 15.6B DKK | — |
| Zealand Pharma A/S ZEAL.CO | +1.17% | 15.5B DKK | 6.1 |
More on NOVO-B
Open NOVO-B.CO in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.